Endo T, Kawakami M, Goto A, America T, Weisbeek P, Nakai M
Department of Chemistry, Faculty of Science, Nagoya University, Chikusa-ku, Japan.
Eur J Biochem. 1994 Oct 1;225(1):403-9. doi: 10.1111/j.1432-1033.1994.00403.x.
Proteins have to be at least partially unfolded upon passage through the biological membranes. Previous studies with a dihydrofolate reductase fusion protein containing a chloroplast transit peptide showed that stabilization of the tertiary structure of the fusion protein by binding of a ligand, methotrexate, failed to block its translocation across the envelopes, suggesting that chloroplast envelopes have strong activity to unfold proteins [America, T., Hageman, J., Guéra, A., Rook, F., Archer, K., Keegstra, K. & Weisbeek, P. (1994) Plant Mol. Biol. 24, 283-294]. In the present study, we have analyzed in vitro translocation of a fusion protein consisting of the entire plastocyanin precursor and dihydrofolate reductase across the chloroplast envelope membranes and the thylakoid membrane. In the presence of methotrexate, the fusion protein was imported into the stroma but its translocation across the thylakoid membrane was blocked. The fusion protein that bound to the envelope became susceptible to digestion by thermolysin. These results suggest that, while the envelope membranes can unfold the methotrexate-bound fusion protein to allow its passage, the thylakoid membrane cannot unfold the fusion protein that has re-bound to methotrexate in the stroma.
蛋白质在穿过生物膜时必须至少部分展开。先前对含有叶绿体转运肽的二氢叶酸还原酶融合蛋白的研究表明,通过配体甲氨蝶呤结合来稳定融合蛋白的三级结构并不能阻止其穿过包膜的转运,这表明叶绿体包膜具有很强的使蛋白质展开的活性[America, T., Hageman, J., Guéra, A., Rook, F., Archer, K., Keegstra, K. & Weisbeek, P. (1994) Plant Mol. Biol. 24, 283 - 294]。在本研究中,我们分析了由整个质体蓝素前体和二氢叶酸还原酶组成的融合蛋白在体外穿过叶绿体包膜膜和类囊体膜的转运情况。在甲氨蝶呤存在的情况下,融合蛋白被导入基质,但它穿过类囊体膜的转运被阻断。与包膜结合的融合蛋白变得易受热溶素消化。这些结果表明,虽然包膜膜可以使与甲氨蝶呤结合的融合蛋白展开以允许其通过,但类囊体膜不能使在基质中重新与甲氨蝶呤结合的融合蛋白展开。